Source: firstwordpharma

Innovus Pharma: Aytu BioScience Completes Acquisition of Innovus Pharmaceuticals

Aytu BioScience Enters Consumer Healthcare Market with a Portfolio of Over 35 Products that Generated $24M in Revenue During Past Four Quarters

Read full article »
Innovus Pharma's Competitors | Innovus Pharma's News | Innovus Pharma's Financials
Stay up-to-date with the latest news on Innovus Pharma
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Bassam Damaj's photo - President & CEO of Innovus Pharma

President & CEO

Bassam Damaj

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Innovus Pharma